Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1969 Aug;48(8):1552–1559. doi: 10.1172/JCI106121

Cellular transport of l-histidine in Hartnup disease

Sverre Halvorsen 1,2,3, Olof Hygstedt 1,2,3, Rudolf Jagenburg 1,2,3, Ottar Sjaastad 1,2,3
PMCID: PMC322382  PMID: 5796364

Abstract

The urinary excretion, the intestinal absorption, and the elimination of histidine from blood were studied in two patients with Hartnup disease. On standard diet the patients lost a great proportion of the dietary histidine in the urine, whereas the fecal loss was negligible. A high oral dose of L-histidine gave only a slight increase in plasma histidine and no increase in fecal histidine, but a considerable increase in the urinary histidine output. Intravenously administered L-histidine was eliminated more rapidly than in controls. The lack of increase in plasma histidine after the oral loading may be explained by the rapid elimination from the blood. This was mainly due to a rapid cellular uptake of histidine which is supposed to be a normal reaction of histidine-deprived cells. Thus the only obvious defect in the histidine transport in Hartnup disease is the reabsorption defect in the renal tubules. A generally impaired cellular transport of L-histidine is improbable.

Full text

PDF
1552

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASATOOR A. M., CRASKE J., LONDON D. R., MILNE M. D. Indole production in Hartnup disease. Lancet. 1963 Jan 19;1(7273):126–128. doi: 10.1016/s0140-6736(63)91015-8. [DOI] [PubMed] [Google Scholar]
  2. DELAEY P., HOOFT C., TIMMERMANS J., SNOECK J. BIOCHEMICAL ASPECTS OF THE HARTNUP DISEASE. I. RESULTS OF INTRAVENOUS AND ORAL TRYPTOPHAN LOADING TESTS IN A CASE OF HARTNUP DISEASE. Ann Paediatr. 1964;202:145–160. [PubMed] [Google Scholar]
  3. EVERED D. F. The excretion of amino acids by the human; a quantitative study with ion-exchange chromatography. Biochem J. 1956 Mar;62(3):416–427. doi: 10.1042/bj0620416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. HALVORSEN K., HALVORSEN S. Hartnup disease. Pediatrics. 1963 Jan;31:29–38. [PubMed] [Google Scholar]
  5. KERSHAW T. G., NEAME K. D., WISEMAN G. The effect of semistarvation on absorption by the rat small intestine in vitro and in vivo. J Physiol. 1960 Jun;152:182–190. doi: 10.1113/jphysiol.1960.sp006480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. MILNE M. D. DISORDERS OF AMINO-ACID TRANSPORT. Br Med J. 1964 Feb 8;1(5379):327–336. doi: 10.1136/bmj.1.5379.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. STEIN W. H., MOORE S. The free amino acids of human blood plasma. J Biol Chem. 1954 Dec;211(2):915–926. [PubMed] [Google Scholar]
  8. Seakins J. W., Ersser R. S. Effects of amino acid loads on a health infant with the biochemical features of Hartnup disease. Arch Dis Child. 1967 Dec;42(226):682–688. doi: 10.1136/adc.42.226.682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Sjaastad O., Halvorsen S. Histaminuria in Hartnup disease. Acta Paediatr Scand. 1968 Jul;57(4):289–293. doi: 10.1111/j.1651-2227.1968.tb07294.x. [DOI] [PubMed] [Google Scholar]
  10. Tada K., Hirono H., Arakawa T. Endogenous renal clearance rates of free amino acids in prolinuric and Hartnup patients. Tohoku J Exp Med. 1967 Sep;93(1):57–61. doi: 10.1620/tjem.93.57. [DOI] [PubMed] [Google Scholar]
  11. VAUGHAN B. E., BOLING E. A. Rapid assay procedures for tritium-labeled water in body fluids. J Lab Clin Med. 1961 Jan;57:159–164. [PubMed] [Google Scholar]
  12. Wong P. W., Lambert A. M., Pillai P. M., Jones P. M. Observations on nicotinic acid therapy in Hartnup disease. Arch Dis Child. 1967 Dec;42(226):642–646. doi: 10.1136/adc.42.226.642. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES